Scope Fluidics S.A.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SCP.WA research report →
About the company
Scope Fluidics S. A. is a biotechnology firm dedicated to conceiving and advancing initiatives that harness microfluidic technologies within medical diagnostics and the broader healthcare landscape.
- CEO
- Piotr Garstecki
- IPO
- 2017
- Employees
- 70
- HQ
- Warsaw, PL
Price Chart
- Market Cap
- $324.93M
- P/E
- -8.02
- P/S
- 3124.34
- P/B
- 2.54
- EV/EBITDA
- -5.52
- Div Yield
- 0.00%
- Gross Margin
- -55270.19%
- Op Margin
- -49404.81%
- Net Margin
- -46959.62%
- ROE
- -35.29%
- ROIC
- -30.00%
- Revenue
- $100.00K · -23.66%
- Net Income
- $-46,364,000 · -170.87%
- EPS
- $-14.64 · -161.00%
- Op Income
- $-47,227,000
- FCF YoY
- -5.25%
- 52W High
- $182.20
- 52W Low
- $109.00
- 50D MA
- $126.56
- 200D MA
- $144.31
- Beta
- 0.00
- Avg Volume
- 2.77K
Get TickerSpark's AI analysis on SCP.WA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our SCP.WA coverage
Recent articles, reports, and earnings notes.
No research on SCP.WA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SCP.WA report →Similar companies
Peers in the same neighborhood.